Medicale Corp.

MCLE

US58464K1025

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 11:20:47 01/07/2024 pm IST			5-day change	1st Jan Change
0.33 ^USD	+22.22%		+484.07%	+120.00%

14/05	Medicale Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
15/02	Medicale Corp Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

Medicale Corp Reports Earnings Results for the First Quarter Ended December 31, 2023

February 15, 2024 at 04:58 pm IST

Medicale Corp reported earnings results for the first quarter ended December 31, 2023. For the first quarter, the company reported net loss was USD 0.019307 million compared to USD 0.008259 million a year ago.

Latest news about Medicale Corp.

Medicale Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	14/05	CI
Medicale Corp Reports Earnings Results for the First Quarter Ended December 31, 2023	15/02	CI
Medicale Corp Reports Earnings Results for the Full Year Ended September 30, 2023	02/01	CI
Medicale Corp Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	15/23/15	CI
Medicale Corp Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	22/23/22	CI

Chart Medicale Corp.

Duration

Period

More charts

Company Profile

Medicale Corp. intends to offer consulting services and distribution of the dietary supplements. The dietary supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid. The supplement can provide nutrients either extracted from food sources or synthetic, individually or in combination, to enhance the quantity of their consumption. The Company has not commenced any operations.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
MEDICALE CORP.	+120.00%	1.95M
MCKESSON CORPORATION	+26.32%	76.05B
CARDINAL HEALTH, INC.	-4.23%	23.81B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+15.24%	8.8B
SINOPHARM GROUP CO. LTD.	+1.71%	8.29B
HUADONG MEDICINE CO., LTD	-33.21%	6.77B
H. LUNDBECK A/S	+19.66%	5.36B
GALENICA AG	+0.89%	4.06B
EBOS GROUP LIMITED	-8.73%	3.77B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-9.28%	3.39B